Helius Medical Technologies Management
Management criteria checks 2/4
Helius Medical Technologies' CEO is Dane Andreeff, appointed in Aug 2020, has a tenure of 3.75 years. total yearly compensation is $1.64M, comprised of 23.6% salary and 76.4% bonuses, including company stock and options. directly owns 0.001% of the company’s shares, worth $70.30. The average tenure of the management team and the board of directors is 2.9 years and 6.8 years respectively.
Key information
Dane Andreeff
Chief executive officer
US$1.6m
Total compensation
| CEO salary percentage | 23.6% |
| CEO tenure | 3.8yrs |
| CEO ownership | 0.001% |
| Management average tenure | 2.9yrs |
| Board average tenure | 6.8yrs |
Recent management updates
Recent updates
Helius Medical Technologies: A Net-Net Meme Stock In The Making
Aug 23Helius Medical Technologies stock slides 51% after pricing $18M securities offering
Aug 05We Think Helius Medical Technologies (NASDAQ:HSDT) Needs To Drive Business Growth Carefully
Aug 18
Helius Medical makes CEO, CFO appointments
Jun 15Helius Medical Technologies announces reverse stock split
Dec 31Helius Medical Technologies EPS beats by $0.01, beats on revenue
Nov 12CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$2m | US$386k | -US$9m |
| Sep 30 2023 | n/a | n/a | -US$13m |
| Jun 30 2023 | n/a | n/a | -US$10m |
| Mar 31 2023 | n/a | n/a | -US$12m |
| Dec 31 2022 | US$603k | US$368k | -US$14m |
| Sep 30 2022 | n/a | n/a | -US$13m |
| Jun 30 2022 | n/a | n/a | -US$17m |
| Mar 31 2022 | n/a | n/a | -US$19m |
| Dec 31 2021 | US$4m | US$192k | -US$18m |
| Sep 30 2021 | n/a | n/a | -US$17m |
| Jun 30 2021 | n/a | n/a | -US$15m |
| Mar 31 2021 | n/a | n/a | -US$13m |
| Dec 31 2020 | US$23k | n/a | -US$14m |
| Sep 30 2020 | n/a | n/a | -US$17m |
| Jun 30 2020 | n/a | n/a | -US$19m |
| Mar 31 2020 | n/a | n/a | -US$16m |
| Dec 31 2019 | US$79k | n/a | -US$10m |
| Sep 30 2019 | n/a | n/a | -US$10m |
| Jun 30 2019 | n/a | n/a | -US$8m |
| Mar 31 2019 | n/a | n/a | -US$26m |
| Dec 31 2018 | US$107k | n/a | -US$29m |
| Sep 30 2018 | n/a | n/a | -US$27m |
| Jun 30 2018 | n/a | n/a | -US$36m |
| Mar 31 2018 | n/a | n/a | -US$24m |
| Dec 31 2017 | US$140k | n/a | -US$28m |
Compensation vs Market: Dane's total compensation ($USD1.64M) is above average for companies of similar size in the US market ($USD667.96K).
Compensation vs Earnings: Dane's compensation has increased whilst the company is unprofitable.
CEO
Dane Andreeff (57 yo)
3.8yrs
Tenure
US$1,635,226
Compensation
Mr. Dane Carl Andreeff has been the President and Chief Executive Officer of Helius Medical Technologies, Inc. since June 14, 2021 and has been its Director since August 4, 2017. He is the Founder of Andre...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 3.8yrs | US$1.64m | 0.0011% $ 70.3 | |
| CFO, Treasurer | 2.9yrs | US$1.06m | 0.0089% $ 576.0 | |
| Chief Medical Officer | 2.8yrs | US$786.54k | 0% $ 0 | |
| Senior Vice President of Engineering | 2.3yrs | no data | no data |
2.9yrs
Average Tenure
57yo
Average Age
Experienced Management: HSDT's management team is considered experienced (2.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 6.8yrs | US$1.64m | 0.0011% $ 70.3 | |
| CFO, Treasurer | 2yrs | US$1.06m | 0.0089% $ 576.0 | |
| Independent Director | 9.5yrs | US$100.88k | 0.057% $ 3.7k | |
| Independent Director | 2.7yrs | US$103.88k | 0.056% $ 3.7k | |
| Independent Chairman of the Board | 8.4yrs | US$118.88k | 0.060% $ 3.9k | |
| Member of Scientific Advisory Board | 9.5yrs | no data | no data | |
| Independent Director | 3.2yrs | US$90.38k | no data |
6.8yrs
Average Tenure
64.5yo
Average Age
Experienced Board: HSDT's board of directors are considered experienced (6.8 years average tenure).